Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations

NCT01359449 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Infection

Interventions

BIOLOGICAL: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®
BIOLOGICAL: Meningococcal Group C Conjugate vaccine: MenC

Sponsor

Sanofi Pasteur, a Sanofi Company